Optimized for chronic respiratory failure management in hospital and home settings.
Intelligent algorithm-driven pressure adjustment for maximum patient comfort.
Advanced detection and treatment protocols for Central Sleep Apnea (CSA).
Ultra-quiet, compact design perfect for lifestyle-integrated respiratory support.
Thailand has successfully positioned itself as the "Medical Hub of Asia," attracting millions of international patients annually for advanced treatments. Within this ecosystem, the demand for high-quality Bilevel Positive Airway Pressure (BiPAP) systems has surged. This growth is driven by a dual-factor phenomenon: the increasing prevalence of Obstructive Sleep Apnea (OSA) among the local population and the rising need for post-COVID respiratory rehabilitation.
As a leading BiPAP manufacturer, Hangzhou QMS Medical Co., Ltd. recognizes the unique requirements of the Thai market, focusing on high humidity compatibility, energy efficiency, and intuitive localized interfaces.
Globally, the respiratory device market is shifting toward AI-integrated diagnostics and IoT-enabled remote monitoring. In Thailand, this trend is manifesting through "Smart Hospital" initiatives supported by the Ministry of Public Health. Hospitals in Bangkok and Chiang Mai are increasingly adopting BiPAP systems that offer cloud-based data transmission, allowing physicians to monitor patient progress remotely.
Furthermore, the Thai industrial sector is placing a heavy emphasis on TFDA (Thai Food and Drug Administration) compliance. International manufacturers must now provide rigorous clinical evidence and post-market surveillance data to ensure reliability and safety in the local market.
Navigating the Thai regulatory landscape requires expertise. Hangzhou QMS Medical ensures that every BiPAP machine delivered to Thailand meets or exceeds international standards such as ISO 13485 and CE certifications, while actively supporting local distributors with TFDA registration documentation. Our localized support includes:
The future of BiPAP technology lies in Adaptive Servo-Ventilation (ASV) and Predictive AI. Our R&D pipeline focuses on developing sensors that can predict an apnea event before it occurs, adjusting pressure levels in real-time with millisecond precision. For the Thailand market, we are exploring 5G integration to support tele-rehabilitation programs in remote provinces, ensuring quality care reaches every corner of the Kingdom.
Hangzhou QMS Medical Co., Ltd. is a professional manufacturer specializing in medical ventilators, ICU ventilation systems, and respiratory care equipment for healthcare institutions worldwide. Established in 2015, the company is located in Hangzhou, China, a city recognized for its strong medical technology and advanced manufacturing industries.
The company operates a modern production facility covering approximately 10,000 square meters and employs more than 220 skilled professionals, including engineers, technicians, and quality management specialists. QMS Medical focuses on the research, development, production, and supply of respiratory support technologies designed for hospitals, intensive care units, emergency departments, ambulance services, and home healthcare applications.
Its product portfolio includes ICU ventilators, portable ventilators, transport ventilators, emergency respiratory support systems, non-invasive ventilation devices, and intelligent patient monitoring integration solutions. The company continuously invests in product innovation and engineering development to improve ventilation performance, operational reliability, and clinical usability across diverse healthcare environments.
Supported by a dedicated R&D team and advanced manufacturing capabilities, QMS Medical implements comprehensive quality management procedures throughout product design, component sourcing, assembly, testing, and final inspection. Serving customers across Europe, North America, Asia, the Middle East, Africa, and Latin America, Hangzhou QMS Medical Co., Ltd. provides flexible OEM and ODM manufacturing services to meet different market requirements.
User-friendly interface with automatic titration for home sleep therapy.
Versatile modes to accommodate various patient needs in clinical settings.
Cost-effective solution without compromising on critical performance features.
Highly adjustable settings for personalized respiratory therapy plans.
Specialized modes for Complex Sleep Apnea and patient-ventilator synchrony.
Advanced rhythmic breathing support for central neurological respiratory issues.
Integrated technology focused on lowering work-of-breathing for patients.
Direct-from-factory pricing for high-volume hospital procurement in SE Asia.